Medicine and Dentistry
Patient
100%
Chronic Kidney Disease
90%
Acute Kidney Injury
79%
Inpatient
41%
Kidney
41%
Nephropathy
38%
Analysis
29%
Personalized Medicine
29%
Pulmonary Hypertension
27%
Cells
26%
Cardiovascular System
25%
Diseases
23%
Renal Biopsy
23%
Urinary System
22%
Hemodialysis
22%
Creatinine
21%
Biological Marker
18%
Albumin
18%
Kidney
18%
Empagliflozin
18%
Aldosterone
18%
Histopathology
18%
Glomerular Filtration Rate
18%
Fatigue
16%
Mortality
16%
Idiopathic Pulmonary Fibrosis
16%
Therapeutic Procedure
16%
Hypertension
15%
Systolic Blood Pressure
15%
Development
15%
Atlas
14%
Plasma
14%
Intervention Trial
13%
Protein
13%
Kidney Function
13%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
12%
Pathophysiology
12%
Angiography
12%
Heart Failure
12%
Heart Right Ventricle Failure
12%
Combination Therapy
12%
Nephrology
11%
Anti-Inflammatory Drug
11%
Association
11%
Prevalence
11%
Diagnosis
11%
Incidence
11%
Comprehension
11%
Hazard Ratio
10%
Diuretic Agent
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
42%
Chronic Kidney Failure
29%
Hemodialysis
29%
Dialysis
27%
Protein
19%
Biological Marker
18%
Erythropoietin
17%
Fatigue
16%
Albumin
14%
End Stage Renal Disease
14%
Peritonitis
13%
Endotoxemia
12%
Mortality
10%
Hyperkalemia
10%
Diuretics
10%
Pulmonary Hypertension
9%
Ergocalciferol
9%
Shock
9%
Pentoxifylline
9%
Non Insulin Dependent Diabetes Mellitus
9%
Blindness
9%
Atrasentan
9%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
9%
Diuretic Agent
9%
Finerenone
9%
Acute Kidney Failure
9%
Injury
9%
Resistant Hypertension
9%
Kidney Disease
9%
Phloretin
9%
Peritoneal Dialysis Fluid
9%
Dehydration
9%
Morbid Obesity
9%
Pathophysiology
8%
Ghrelin
8%
Heart Failure
8%
Chronic Kidney Failure
8%
Mouse
8%
Cardiogenic Shock
7%
Lipopolysaccharide
7%
Aldosterone Antagonist
7%
Interleukin 6
7%
Branched Chain Amino Acid
7%
Pigment Epithelium Derived Factor
6%
Cadherin
6%
Kidney Fibrosis
6%
Hypertension
6%
Neutrophil Gelatinase Associated Lipocalin
6%
Reactive Oxygen Metabolite
6%
Ischemia
6%
